Cholestatic hepatitis C following liver transplantation: an outcome-based histological definition, clinical predictors, and prognosis (Q44698568)

5 December 2017

Cholestatic hepatitis C following liver transplantation: an outcome-based histological definition, clinical predictors, and prognosis (English)

1 reference

5 December 2017

liver transplantation

1 reference

1 reference

4

Jay Lefkowitch

1 reference

5 December 2017

Elizabeth C Verna

1

1 reference

5 December 2017

Rita Abdelmessih

2

1 reference

5 December 2017

Marcela A Salomao

3

1 reference

5 December 2017

Roger K Moreira

5

1 reference

5 December 2017

Robert S Brown

6

1 reference

5 December 2017

language of work or name

1 reference

1 January 2013

1 reference

5 December 2017

Liver Transplantation

1 reference

5 December 2017

19

1 reference

5 December 2017

1

1 reference

5 December 2017

78-88

1 reference

Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications

5 December 2017

1 reference

Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis

21 January 2018

1 reference

Fibrosing cholestatic hepatitis following cytotoxic chemotherapy for small-cell lung cancer

21 January 2018

1 reference

Rapidly progressive fibrosing cholestatic hepatitis--hepatitis C virus in HIV coinfection.

21 January 2018

1 reference

Fibrosing cholestatic hepatitis in HIV/HCV co-infected transplant patients-usefulness of early markers after liver transplantation

21 January 2018

1 reference

Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection

21 January 2018

1 reference

Cholestatic syndrome with bile duct damage and loss in renal transplant recipients with HCV infection

21 January 2018

1 reference

Hepatitis C virus-related fibrosing cholestatic hepatitis after renal transplantation

21 January 2018

1 reference

Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy

21 January 2018

1 reference

Hepatitis C virus-related fibrosing cholestatic hepatitis after cardiac transplantation: is azathioprine a contributory factor?

21 January 2018

1 reference

Cholestatic hepatitis C in liver allografts

21 January 2018

1 reference

Fibrosing cholestatic hepatitis developing after liver transplantation: case report of a patient with HCV-related cirrhosis

21 January 2018

1 reference

Early, rapidly progressive cholestatic hepatitis C reinfection and graft loss after adult living donor liver transplantation

21 January 2018

1 reference

Early diagnosis and treatment resolved cholestatic hepatitis C without fibrosis after living donor liver transplantation: report of a case

21 January 2018

1 reference

Fibrosing cholestatic hepatitis in a liver transplant recipient with hepatitis C virus infection: a case report

21 January 2018

1 reference

Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.

21 January 2018

1 reference

Sustained resolution of fibrosing cholestatic hepatitis C despite viremic relapse after stopping pegylated interferon and ribavirin therapy

21 January 2018

1 reference

Duration of antiviral therapy for cholestatic HCV recurrence may need to be indefinite

21 January 2018

1 reference

Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury

21 January 2018

1 reference

Hyperbilirubinemia and cholestatic liver injury in hepatitis C-infected liver transplant recipients

21 January 2018

1 reference

Interferon alpha 2B and ribavirin in severe recurrent cholestatic hepatitis C.

21 January 2018

1 reference

High levels of hepatitis C virus RNA in native livers correlate with the development of cholestatic hepatitis in liver allografts and a poor outcome

21 January 2018

1 reference

The importance of clinical parameters when differentiating cholestatic hepatitis C virus from allograft rejection

21 January 2018

1 reference

Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C.

21 January 2018

1 reference

Post-liver transplant cholestatic hepatitis C: a systematic review of clinical and pathological findings and application of consensus criteria

21 January 2018

1 reference

Hepatitis C virus genotypes and quantification of serum hepatitis C RNA in liver transplant recipients. Relationship with histologic outcome of recurrent hepatitis C.

21 January 2018

1 reference

Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels

21 January 2018

1 reference

Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C

21 January 2018

1 reference

Host and donor risk factors before and after liver transplantation that impact HCV recurrence

21 January 2018

1 reference

A model to predict severe HCV-related disease following liver transplantation.

21 January 2018

1 reference

Hepatitis C and liver transplantation: enhancing outcomes and should patients be retransplanted

21 January 2018

1 reference

Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus

21 January 2018

1 reference

Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/LT.23559

1 reference

5 December 2017

1 reference